MALDI TOF News and Research

RSS
Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry is a soft ionization method used in the detection of various chemical compounds with a broad mass range. MALDI-TOF can be applied in biology to the study of nucleic acids and proteins.
Key research takeaways from ECCMID 2019

Key research takeaways from ECCMID 2019

Cannabis Quality and Contamination Testing

Cannabis Quality and Contamination Testing

Genevac’s new web page illustrates advantages of evaporative sample preparation for mass spectrometry

Genevac’s new web page illustrates advantages of evaporative sample preparation for mass spectrometry

Bruker showcases innovative high-performance systems and high-value analytical solutions at Pittcon 2017

Bruker showcases innovative high-performance systems and high-value analytical solutions at Pittcon 2017

RapifleX MALDI PharmaPlus Solution for uHTS launched by Bruker

RapifleX MALDI PharmaPlus Solution for uHTS launched by Bruker

Innovative RapifleX MALDI-TOF/TOF showcased by Bruker

Innovative RapifleX MALDI-TOF/TOF showcased by Bruker

Bruker showcases new products, analytical solutions for improved performance at Analytica 2016

Bruker showcases new products, analytical solutions for improved performance at Analytica 2016

Bruker receives CFDA clearance to market IVD MALDI Biotyper System in China

Bruker receives CFDA clearance to market IVD MALDI Biotyper System in China

Agena Bioscience expands ultrasensitive somatic mutation detection technology

Agena Bioscience expands ultrasensitive somatic mutation detection technology

Agena Bioscience acquires Sequenom’s Bioscience business

Agena Bioscience acquires Sequenom’s Bioscience business

New method for identifying bacteria in patient specimens leads to 92% cost reduction

New method for identifying bacteria in patient specimens leads to 92% cost reduction

Bruker launches new, improved customer-driven products at Pittcon 2014

Bruker launches new, improved customer-driven products at Pittcon 2014

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Early detection of breast cancer could soon be possible with blood test

Early detection of breast cancer could soon be possible with blood test

Sequenom announces Certified Service Provider program for technical certification

Sequenom announces Certified Service Provider program for technical certification

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

Bruker launches BioPharmaCompass 1.1 software

Bruker launches BioPharmaCompass 1.1 software

Accelr8 expands development plan for BACcel rapid diagnostic test

Accelr8 expands development plan for BACcel rapid diagnostic test

Bruker to showcase record performance achievements of maXis 4G system at ASMS 2011

Bruker to showcase record performance achievements of maXis 4G system at ASMS 2011